Evidence map›Paper›PMID 35538079›Full record

ArticleNature communications2022

Serum metabolome associated with severity of acute traumatic brain injury.

Ilias Thomas, Alex M Dickens, Jussi P Posti, Endre Czeiter, Daniel Duberg, Tim Sinioja, Matilda Kråkström, Isabel R A Retel Helmrich, Kevin K W Wang, Andrew I R Maas and 7 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07782216 (Investigating the Significance of Protein Biomarkers During the Hyperacute Phase of Traumatic Brain Injury and Other CNS Conditions With Hypoxia/Hypoperfusion in Emergency and Prehospital Settings), which is not on this map. Cited by 66 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 1 pooled it
13.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07782216 recruitingnot on this mapstarted 2026, after this paper: background citation

Investigating the Significance of Protein Biomarkers During the Hyperacute Phase of Traumatic Brain Injury and Other CNS Conditions With Hypoxia/Hypoperfusion in Emergency and Prehospital Settings (CHARON)

TypeobservationalSponsorUniversity of PecsRan2026 to 2028Enrolled477ConditionsBrain Injuries, Traumatic, Brain Injuries, Acute, Hypoxia, Brain, Cardiac Arrest (CA)
3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 1 synthesis or guideline pooled it, 107 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Nanozyme-based therapeutic strategies for traumatic brain injury.International journal of pharmaceutics: X · 2026
    Review
  4. Article
  5. Article
  6. Research progress on biomarkers of traumatic brain injury.Animal models and experimental medicine · 2026
    Review
  7. Article
  8. Review
  9. Metabolomics of cerebrospinal fluid following traumatic brain injury: Exploration of biomarkers for secondary injuries and severity.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Article
  10. Article
  11. Article
  12. Review
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Metabolomic alterations in human brain microvascular endothelial cells induced by traumatic injury.Metabolomics : Official journal of the Metabolomic Society · 2025
    Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 20 institutions in 24 countries.

Ilias ThomasSchool of Medical Sciences, Örebro University, Örebro, Sweden.
Alex M DickensTurku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.
Jussi P PostiNeurocenter, Department of Neurosurgery and Turku Brain Injury Center, Turku University Hospital and University of Turku, Turku, Finland.ORCID 0000-0002-5925-5193
Endre CzeiterDepartment of Neurosurgery, Medical School, University of Pécs, Pécs, Hungary.ORCID 0000-0002-9578-6944
Daniel DubergDepartment of Chemistry, Örebro University, Örebro, Sweden.
Tim SiniojaDepartment of Chemistry, Örebro University, Örebro, Sweden.
Matilda KråkströmTurku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.
Isabel R A Retel HelmrichDepartment of Public Health, Center for Medical Decision Making, Erasmus MC-University Medical Center, Rotterdam, The Netherlands.
Kevin K W WangProgram for Neurotrauma, Neuroproteomics & Biomarkers Research, Department of Emergency Medicine, McKnight Brin Institute of the University of Florida, Gainesville, Florida, USA.
Andrew I R MaasDepartment of Neurosurgery, Antwerp University Hospital and University of Antwerp, Edegem, Belgium.ORCID 0000-0003-1612-1264
Ewout W SteyerbergDepartment of Public Health, Center for Medical Decision Making, Erasmus MC-University Medical Center, Rotterdam, The Netherlands.ORCID 0000-0002-7787-0122
David K MenonDivision of Anaesthesia, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.ORCID 0000-0002-3228-9692
Olli TenovuoNeurocenter, Department of Neurosurgery and Turku Brain Injury Center, Turku University Hospital and University of Turku, Turku, Finland.
Tuulia HyötyläinenDepartment of Chemistry, Örebro University, Örebro, Sweden.
András BükiSchool of Medical Sciences, Örebro University, Örebro, Sweden.
Matej OrešičSchool of Medical Sciences, Örebro University, Örebro, Sweden. matej.oresic@oru.se.ORCID 0000-0002-2856-9165
CENTER-TBI Participants and Investigators
Erasmus MC · NLUniversity of Cambridge · GBUniversity of Pecs · HUFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITKarolinska Institutet · SEMonash University · AUUniversity of Antwerp · BEAssistance Publique – Hôpitaux de Paris · FRÖrebro University · SEAuckland University of Technology · NZLeiden University Medical Center · NLOslo University Hospital · NOUniversity of Liège · BEUniversity of Novi Sad · RSUniversity of Trnava · SKUniversity of Turku · FIÅbo Akademi University · FIBroad Institute · USHeidelberg University · DEHospital Universitario 12 De Octubre · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Complex metabolic disruption is a crucial aspect of the pathophysiology of traumatic brain injury (TBI). Associations between this and systemic metabolism and their potential prognostic value are poorly understood. Here, we aimed to describe the serum metabolome (including lipidome) associated with acute TBI within 24 h post-injury, and its relationship to severity of injury and patient outcome. We performed a comprehensive metabolomics study in a cohort of 716 patients with TBI and non-TBI reference patients (orthopedic, internal medicine, and other neurological patients) from the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) cohort. We identified panels of metabolites specifically associated with TBI severity and patient outcomes. Choline phospholipids (lysophosphatidylcholines, ether phosphatidylcholines and sphingomyelins) were inversely associated with TBI severity and were among the strongest predictors of TBI patient outcomes, which was further confirmed in a separate validation dataset of 558 patients. The observed metabolic patterns may reflect different pathophysiological mechanisms, including protective changes of systemic lipid metabolism aiming to maintain lipid homeostasis in the brain.

Indexed as

Brain InjuriesBrain Injuries, TraumaticCohort StudiesHumansMetabolomeMetabolomics

Identifiers

PMID35538079
PMCPMC9090763
OpenAlexW4229453280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.